1. Home
  2. IMXI vs EYPT Comparison

IMXI vs EYPT Comparison

Compare IMXI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

N/A

Current Price

$14.37

Market Cap

469.3M

Sector

Technology

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$4.79

Market Cap

419.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IMXI
EYPT
Founded
1994
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
419.9M
IPO Year
2016
2005

Fundamental Metrics

Financial Performance
Metric
IMXI
EYPT
Price
$14.37
$4.79
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$15.00
$31.80
AVG Volume (30 Days)
655.1K
6.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$319,601,000.00
$7,539,000.00
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
$3,115.57
P/E Ratio
$95.90
N/A
Revenue Growth
16.68
N/A
52 Week Low
$11.15
$3.95
52 Week High
$15.95
$19.11

Technical Indicators

Market Signals
Indicator
IMXI
EYPT
Relative Strength Index (RSI) 60.66 31.68
Support Level $13.98 $3.95
Resistance Level $14.86 $15.17
Average True Range (ATR) 0.28 0.49
MACD 0.08 -0.06
Stochastic Oscillator 53.06 40.08

Price Performance

Historical Comparison
IMXI
EYPT

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: